AstraZeneca’s Lokelma Approved In US With Label Benefits Over Veltassa

 
• By Lucie Ellis-Taitt
  
Dollar sign
Analysts ponder whether late-to-market Lokelma can still reach blockbuster status • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip